RxDoctor Payments Data

Ashton Crook, NP

Family · Lima, OHNPI 1871849828

Payments from drug & device makers

$234in general payments, 2019–2025

Across 13 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$42
  • Xeris Pharmaceuticals, Inc.$41
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$24
  • Amgen$23
  • Abbott$23
  • Exact Sciences$21
  • plus $59 from 4 others

What the payments were for

  • Food & beverage$23299%
  • Education$21%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$234 in reported general payments places this provider in the 40th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$36,001
Medicare patients
126
Services billed
678

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide55$80,297
MounjaroTirzepatide37$59,703
FarxigaDapagliflozin Propanediol26$35,323
TrulicityDulaglutide23$32,208
EliquisApixaban18$29,715
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$20,640
JanuviaSitagliptin Phosphate14$19,448
JardianceEmpagliflozin16$18,655
LinzessLinaclotide26$15,396
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr15$8,152
Advair HfaFluticasone Propion/Salmeterol16$6,436
Gabapentin122$3,747
Atorvastatin Calcium192$1,949
Duloxetine Hcl44$1,891
Pantoprazole Sodium131$1,693

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$16$91,91260 claims
AstraZenecaFarxiga$42$35,32326 claims
PfizerEliquis$21$29,71518 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 6,812 family providers in Ohio.

Other family in Lima

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →